DK694687D0 - Hidtil ukendte oligosaccharider, immunogener og vacciner og fremgangsmaader til fremstilling af disseoligosaccharider, immunogener og vacciner - Google Patents

Hidtil ukendte oligosaccharider, immunogener og vacciner og fremgangsmaader til fremstilling af disseoligosaccharider, immunogener og vacciner

Info

Publication number
DK694687D0
DK694687D0 DK694687A DK694687A DK694687D0 DK 694687 D0 DK694687 D0 DK 694687D0 DK 694687 A DK694687 A DK 694687A DK 694687 A DK694687 A DK 694687A DK 694687 D0 DK694687 D0 DK 694687D0
Authority
DK
Denmark
Prior art keywords
immunogens
vaccines
unknown
oligosaccharides
disseoligosaccharides
Prior art date
Application number
DK694687A
Other languages
English (en)
Other versions
DK694687A (da
Inventor
Eduar Coen Beuvery
Adolf Evenberg
Jan Theunis Poolman
Jacobus Hubertus Van Boom
Peter Hoogerhout
Constant Adriaan Anton Boeckel
Original Assignee
Nederlanden Staat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nederlanden Staat filed Critical Nederlanden Staat
Publication of DK694687D0 publication Critical patent/DK694687D0/da
Publication of DK694687A publication Critical patent/DK694687A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK694687A 1986-12-31 1987-12-30 Hidtil ukendte oligosaccharider, immunogener og vacciner og fremgangsmaader til fremstilling af disseoligosaccharider, immunogener og vacciner DK694687A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8603325 1986-12-31

Publications (2)

Publication Number Publication Date
DK694687D0 true DK694687D0 (da) 1987-12-30
DK694687A DK694687A (da) 1988-07-01

Family

ID=19849078

Family Applications (1)

Application Number Title Priority Date Filing Date
DK694687A DK694687A (da) 1986-12-31 1987-12-30 Hidtil ukendte oligosaccharider, immunogener og vacciner og fremgangsmaader til fremstilling af disseoligosaccharider, immunogener og vacciner

Country Status (15)

Country Link
US (1) US5034519A (da)
EP (1) EP0276516B1 (da)
JP (1) JPS63190896A (da)
KR (1) KR880007557A (da)
AT (1) ATE87003T1 (da)
AU (1) AU603405B2 (da)
CA (1) CA1335405C (da)
DE (1) DE3784907T2 (da)
DK (1) DK694687A (da)
ES (1) ES2054657T3 (da)
FI (1) FI89172C (da)
IE (1) IE59734B1 (da)
NO (1) NO169775C (da)
NZ (1) NZ223009A (da)
PT (1) PT86484B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0320942A3 (en) * 1987-12-18 1989-10-04 American Cyanamid Company Novel polysaccharides novel macromolecular conjugates of the polysaccharides
DE68915046T2 (de) * 1988-04-19 1994-12-08 American Cyanamid Co Haemophilus influenzae Typ B Polysaccharid-Aussermembranprotein-Konjugat als Impfstoff.
US7118757B1 (en) * 1988-12-19 2006-10-10 Wyeth Holdings Corporation Meningococcal class 1 outer-membrane protein vaccine
EP0378929A3 (en) * 1988-12-23 1990-08-01 Connaught Laboratories Limited Membrane proteins and peptides of haemophilus influenzae type b
GB8924473D0 (en) * 1989-10-31 1989-12-20 Connaught Lab Outer membrane protein p1 and peptides of haemophilus influenzae b
NZ239643A (en) * 1990-09-17 1996-05-28 North American Vaccine Inc Vaccine containing bacterial polysaccharide protein conjugate and adjuvant (c-nd-che-a-co-b-r) with a long chain alkyl group.
US5153312A (en) * 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
DE69130955T2 (de) * 1990-12-21 1999-07-01 Antex Biologics, Inc., Gaithersburg, Md. Adhesin-oligosaccharid-impfstoffkonjugate für -i(haemophilus influenza)
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
CA2059693C (en) * 1991-01-28 2003-08-19 Peter J. Kniskern Polysaccharide antigens from streptococcus pneumoniae
US5409705A (en) * 1991-05-20 1995-04-25 Kao Corporation Phosphobetaine and detergent and cosmetic containing the same
US5371197A (en) * 1991-09-24 1994-12-06 Merck & Co., Inc. Protein-dimeric polysaccharide conjugate vaccine
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
PT647140E (pt) * 1992-06-25 2007-12-27 Univ Georgetown Vacinas de papilomavírus
US7148031B2 (en) 1994-07-26 2006-12-12 The Mitre Corporation Sequestering of glycoprotein molecules and oligosaccharide moieties in lipo-glycoprotein membranes and micelles
US5762256A (en) 1995-08-28 1998-06-09 United States Surgical Corporation Surgical stapler
US5782396A (en) * 1995-08-28 1998-07-21 United States Surgical Corporation Surgical stapler
US6032849A (en) * 1995-08-28 2000-03-07 United States Surgical Surgical stapler
SE9601158D0 (sv) * 1996-03-26 1996-03-26 Stefan Svenson Method of producing immunogenic products and vaccines
DE69708318T3 (de) * 1996-08-27 2006-11-16 Novartis Vaccines and Diagnostics, Inc., Emeryville Neisseria meningitidis serogruppe b glykokonjugate und verfahren zu deren verwendung
US6267961B1 (en) * 1996-11-22 2001-07-31 Baxter International Inc. Direct methods for molar-mass determination of fragments of Haemophilus influenzae type b capsular polysaccharides and vaccine preparation
CU22904A1 (es) * 1999-08-30 2004-01-23 Univ De Ottawa Oligosacáridos derivados de ribosa- ribitol-fosfato, métodos para prepararlos, inmunógenos que los comprenden y vacunas que comprenden dichos inmunógenos
US8785134B2 (en) 2008-11-10 2014-07-22 The Mitre Corporation Glycoprotein vesicles and their methods of use
AU2017302136B2 (en) 2016-07-28 2021-05-27 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Stable hydrolysis-resistant synthetic polyribosylribitolphosphate derivatives as vaccines against haemophilus influenzae type b
CN108776223B (zh) * 2018-04-19 2021-04-06 广州质量监督检测研究院 紫外吸收剂uv-326检测试剂盒及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220717A (en) * 1977-12-22 1980-09-02 American Cyanamid Company Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
US4264764A (en) * 1979-01-12 1981-04-28 Merck & Co., Inc. Meningitis vaccine
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4451446A (en) * 1982-03-04 1984-05-29 Smithkline-Rit Process for the preparation of polysaccharide-protein complexes from bacterial capsules, obtained products and immunogenic compositions containing them
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
US4644059A (en) * 1982-07-06 1987-02-17 Connaught Laboratories, Inc. Haemophilus influenzae B polysaccharide-diptheria toxoid conjugate vaccine
US4459286A (en) * 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine

Also Published As

Publication number Publication date
EP0276516B1 (en) 1993-03-17
ATE87003T1 (de) 1993-04-15
NO875442L (no) 1988-07-01
IE873510L (en) 1988-06-30
NZ223009A (en) 1990-06-26
JPS63190896A (ja) 1988-08-08
EP0276516A3 (en) 1988-08-17
PT86484B (pt) 1990-11-20
KR880007557A (ko) 1988-08-27
DE3784907T2 (de) 1993-06-24
AU603405B2 (en) 1990-11-15
PT86484A (en) 1988-01-01
DK694687A (da) 1988-07-01
FI875727L (fi) 1988-07-01
EP0276516A2 (en) 1988-08-03
DE3784907D1 (de) 1993-04-22
FI89172C (fi) 1993-08-25
US5034519A (en) 1991-07-23
AU8314587A (en) 1988-07-07
FI89172B (fi) 1993-05-14
ES2054657T3 (es) 1994-08-16
NO169775B (no) 1992-04-27
NO169775C (no) 1992-08-05
CA1335405C (en) 1995-04-25
IE59734B1 (en) 1994-03-23
FI875727A0 (fi) 1987-12-28
NO875442D0 (no) 1987-12-28

Similar Documents

Publication Publication Date Title
DK694687A (da) Hidtil ukendte oligosaccharider, immunogener og vacciner og fremgangsmaader til fremstilling af disseoligosaccharider, immunogener og vacciner
FR2499412B1 (fr) Production de vaccin antivirus
DK497488D0 (da) 6-(((substituerede)-pyridin-3-yl)-alkyl)- og alkenyl)- tetrahydro-4-hydroxypyran-2-on-derivater og ffremgangsmaade til fremstilling deraf
IT8747856A0 (it) Adiuvante immunologico per vaccini polisaccaridici
DE69120040D1 (de) Selbsthärtende keramisierbare Polysiloxane
DK49687D0 (da) (-)-benzhydrylsulfinylacetamid, fremgangsmaade til fremstilling heraf og laegemiddel indeholdende denne forbindelse
NO852567L (no) Thymopentinanaloger og fremgangsmmaate for deres fremstilling.
NO872462D0 (no) Fremgangsmaate for fremstilling av kondenserte, cykliske azepin-2-on-derivater.
DE68915915D1 (de) Verfahren zur Herstellung von cyclischen Polysiloxanen.
NO174325C (no) Fremgangsmåte for fremstilling av sfæroider som inneholder kalsiumblokker
LU80063A1 (fr) Procede de preparation d'un vaccin de masse moleculaire elevee contre la meningite a meningocoques du groupe c
NO175735C (no) Fremgangsmåte ved fremstilling av Pasteurella-vaksine
DK0515415T3 (da) Hidtil ukendt vaccine og fremgangsmåde til fremstilling deraf
IT8621142A0 (it) Procedimento perfezionato per lapreparazione di anidride borica.
DK592284D0 (da) Toxoid, vaccinepraeparat indeholdende det og fremgangsmaade til fremstilling af det
NO174085C (no) Fremgangsmåte for fremstilling av sukralfatpreparater
DK155886D0 (da) Vaccine og fremgangsmaade til fremstilling af denne
FI93423C (fi) Menetelmä rokotteen valmistamiseksi
DK42083D0 (da) Fremgangsmade til fremstilling af et immunogen af pasteurella multocida
DK621688D0 (da) Ethylerede avermectiner og praeparater indeholdende disse til behandling og forhindring af parasitinfektioner hos mennesker og dyr
DK313687A (da) Fremgangsmaade til fremstilling af et antigen og vaccine indeholdende dette antigen
DK343988D0 (da) Praeparater med kontrolleret afgivelseshastighed af nulte orden, og fremgangsmaade til fremstilling af saasanne praeparater
PT86745A (pt) Process for preparing oxime ethers of 2,6-dioxabicyclo ]3.3.o" octanones
DK315487D0 (da) Methylenderivater af androst-4-en-3,17-dioner og fremgangsmaade til fremstilling deraf
NO882224L (no) Fremgangsmaate for fremstilling av analoger av alfa-msh.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment